ChemotherapyFDA-approvedFirst-line
L-asparaginase
How it works
Depletes the amino acid asparagine, which is necessary for cancer cell growth and survival.
Cancer types
Leukemia— All patients
Efficacy
In clinical trials, around 90% of patients achieved complete remission with l-asparaginase-based therapy.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.